Nu-Med Plus (NUMD) Long-Term Debt Issuances (2012 - 2025)
Nu-Med Plus recorded quarterly Long-Term Debt Issuances of $33767.0 in Q4 2025, up 259.84% quarter-over-quarter from $9384.0 in Q2 2020.
Nu-Med Plus' Long-Term Debt Issuances history runs 4 years deep, the most recent figure standing at $33767.0 for Q4 2025.
- In Q4 2025, Long-Term Debt Issuances changed N/A year-over-year to $33767.0; the TTM figure through Dec 2025 stood at $33767.0 (changed N/A YoY), while the FY2025 annual figure was $46267.0, changed N/A from the prior year.
- Long-Term Debt Issuances came in at $33767.0 for Q4 2025 at Nu-Med Plus, up from $9384.0 in the prior quarter.
- In the past five years, Long-Term Debt Issuances ranged from a high of $33767.0 in Q4 2025 to a low of $33767.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 19.86 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 11.71 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 1.15 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Nu-Med Plus | - | - | - | 33,767.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 33,767.00 |
| Dec 31, 2025 | 33,767.00 |
| Jun 30, 2020 | 9,384.00 |
| Jun 30, 2020 | 9,384.00 |
| Sep 30, 2013 | 40,000.00 |
| Sep 30, 2013 | 40,000.00 |
| Jun 30, 2013 | 37,500.00 |
| Jun 30, 2013 | 37,500.00 |
| Mar 31, 2013 | 39,100.00 |
| Mar 31, 2013 | 39,100.00 |
| Dec 31, 2012 | 40,408.00 |
| Dec 31, 2012 | 40,408.00 |
| Sep 30, 2012 | 10,000.00 |
| Sep 30, 2012 | 10,000.00 |
| Jun 30, 2012 | -208.00 |
| Jun 30, 2012 | -208.00 |
| Mar 31, 2012 | 208.00 |
| Mar 31, 2012 | 208.00 |